Open an account

Ashland

ASH · NYSE

$71.69+$0.50 (+0.70%)TodayMarket closed ·
Prev close $71.19

About ASH

Ashland, Inc. is an additives and specialty ingredients company, which engages in the provision of architectural coatings, construction, energy, food and beverage, nutraceuticals, personal care, and pharmaceutical products. The company is headquartered in Wilmington, Delaware and currently employs 2,900 full-time employees. The firm serves customers in a wide range of consumer and industrial markets, including architectural coatings, construction, energy, food and beverage, personal care and pharmaceuticals. The Company’s segments include Life Sciences, Personal Care, Specialty Additives, and Intermediates. The Life Sciences segment consists of pharmaceuticals, nutrition, agricultural chemicals, diagnostic films and fine chemicals. The Personal Care segment includes functionals, microbial protectants (preservatives), skin care, sun care, oral care, hair care and household solutions. The Specialty Additives segment consists of rheology and performance-enhancing additives serving the architectural coatings, construction, energy, automotive and various industrial markets. The Intermediates segment consists of the production of 1,4 butanediol (BDO) and related derivatives, including n-methyl pyrrolidone.

Employees
2,900
Headquarters
Wilmington, Delaware
Listed
Mar 17, 1980
Sector
Materials
Industry
Chemicals
Website
ashland.com

ASH key statistics

Market cap
3.26B
Price-earnings ratio
129.44
Dividend yield
2.32%
Average volume
584.69K
Volume
387.57K
Open price
$71.25
High today
$72.16
Low today
$71.25
52 Week high
$78.25
52 Week low
$47.12

Ashland (ASH) at a glance

As of Oct 20, 2026, Ashland (ASH) shares are priced at $71.69, giving the company a market cap of 3.26B, a price-to-earnings ratio of 129.44 and a dividend yield of 2.32%.

Today the stock has traded between $71.25 and $72.16. The current price is 0.6% above the day's low and 0.7% below its high.

Volume so far is 387.57K shares, below the average of 584.69K shares a day.

Over the past year Ashland has ranged from $47.12 to $78.25, and now sits 79% of the way up that range.

Ashland met or beat analyst EPS estimates in 3 of the last 8 quarters. In Q2 FY26 it reported $1.02 per share against an estimate of $0.9953.

The average analyst price target is $81.90, 14.2% above the current price, from 10 recent ratings.

Analyst ratings

Latest rating from each analyst over the past 12 months

60%of 10 analyst ratings say Buy
  • Buy60.0%
  • Hold40.0%
  • Sell0.0%
Price target · 13 analystsAvg $81.90
Low
$70.70
Now
$71.69
High
$94.50

ASH earnings

Earnings per share, reported against the analyst estimate

Beat the estimate in 3 of the last 8 quarters, by 19.8% on average.

  1. Q3 FY24: reported $1.49 per share against an estimate of $1.46
  2. Q4 FY24: reported $1.26 per share against an estimate of $1.30
  3. Q1 FY25: reported $0.28 per share against an estimate of $0.1805
  4. Q2 FY25: reported $0.99 per share against an estimate of $1.11
  5. Q3 FY25: reported $1.04 per share against an estimate of $1.24
  6. Q4 FY25: reported $1.08 per share against an estimate of $1.26
  7. Q1 FY26: reported $0.91 per share against an estimate of $0.9461
  8. Q2 FY26: reported $1.02 per share against an estimate of $0.9953

ASH news

  • Press releaseGlobe Newswire

    Ashland scales Transformed Vegetable Oils technology platform in crop care, launches agrimer™ eco-disperse OD polymeric dispersant

  • Press releaseGlobe Newswire

    Ashland advances high-growth oral biologics delivery applications with launch of permexa™ sodium caprate

  • Press releaseGlobe Newswire

    Ashland reports third quarter 2026 results and reaffirms full-year sales & Adjusted EBITDA outlook

  • Press releaseGlobe Newswire

    Ashland announces appointment of two new directors as part of Cooperation Agreement with stockholder Ancora

  • 'Chemical-Maker Ashland Is Said to Near Settlement With Ancora' - Bloomberg

  • Press releaseBusiness Wire

    ITT Announces Appointment of Bertrand Loy and Kevin Wheeler to Board of Directors

  • 'Chemicals Maker Ashland Pushed to Sell by Activist Cruiser' - Bloomberg

  • Press releaseBusiness Wire

    Ancora Releases Presentation Highlighting the Opportunity for a Value-Maximizing, Competitive Sale Process at Ashland Inc.

Similar companies

Companies in the same industry as Ashland

Most active stocks

Highest trading volume today

Newly listed

Companies that went public in the past six weeks

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.